---
$id: https://graph.org.ai/products/commodity/51111849
$type: Product
source: UNSPSC
code: "51111849"
title: "Fosfestrol"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fosfestrol

**UNSPSC Code**: 51111849
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hormonal antineoplastic agent with the molecular formula C18H22O8P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0E0NMA80F, chemically known as 4,4-stilbenediol, .alpha., .alpha.-diethyl-, diphosphate, disodium salt but generally known as fosfestrol, which bears US NIH Compound Identifier 3032325. European Medicines Agency schedules Fosfestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07795MIG. World Health Organization schedules fosfestrol in its Anatomical Therapeutic Chemical (ATC) Classification. FOSFESTROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fosfestrol under HS 29199090 and SITC 51631. As of Q4 2014, FOSFESTROL remains the US FDA Preferred Term for this commodity. Fosfestrol bears US NLM identifiers UMLS ID C0060692 and NCI Concept Code C1105. SMILES: P(=O)(OC1CCC(C(=C(\CC)C2CCC(OP(=O)(O)O)CC2)/CC)CC1)(O)O.

